Chongkai Fang

477 total citations
24 papers, 161 citations indexed

About

Chongkai Fang is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Chongkai Fang has authored 24 papers receiving a total of 161 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Chongkai Fang's work include Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Mechanisms and Therapy (4 papers). Chongkai Fang is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Mechanisms and Therapy (4 papers). Chongkai Fang collaborates with scholars based in China and United Kingdom. Chongkai Fang's co-authors include Chong Zhong, Jinan Wang, Junyan Wang, Zihao Wang, Longhua Mu, Silin Liu, Ji-Nan Wang, Jietao Lin, Qingzhong Xiao and Zhiwei Xiao and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Chongkai Fang

19 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chongkai Fang China 9 71 58 42 42 27 24 161
Haofeng Lu China 5 127 1.8× 94 1.6× 24 0.6× 29 0.7× 29 1.1× 9 205
Yuwen Qi China 8 74 1.0× 66 1.1× 32 0.8× 40 1.0× 32 1.2× 16 158
Jinzhe Zhou China 11 147 2.1× 94 1.6× 44 1.0× 43 1.0× 39 1.4× 21 255
Linghua Zhu China 9 130 1.8× 83 1.4× 57 1.4× 34 0.8× 44 1.6× 26 263
Juliang He China 10 114 1.6× 71 1.2× 46 1.1× 44 1.0× 52 1.9× 19 250
Wen‐Bin Ding China 6 75 1.1× 51 0.9× 25 0.6× 49 1.2× 28 1.0× 11 199
Jun Wen China 9 122 1.7× 61 1.1× 77 1.8× 78 1.9× 66 2.4× 14 275
Yumin Wu China 8 104 1.5× 53 0.9× 65 1.5× 32 0.8× 24 0.9× 13 202
Yanan Xu China 8 118 1.7× 86 1.5× 28 0.7× 56 1.3× 75 2.8× 14 287

Countries citing papers authored by Chongkai Fang

Since Specialization
Citations

This map shows the geographic impact of Chongkai Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongkai Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongkai Fang more than expected).

Fields of papers citing papers by Chongkai Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chongkai Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongkai Fang. The network helps show where Chongkai Fang may publish in the future.

Co-authorship network of co-authors of Chongkai Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Chongkai Fang. A scholar is included among the top collaborators of Chongkai Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chongkai Fang. Chongkai Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Fang, Chongkai, et al.. (2025). Jianpi Huayu decoction enhances the antitumor effect of doxorubicin via piezo1-mediated autophagy in hepatocellular carcinoma. Phytomedicine. 143. 156908–156908. 3 indexed citations
5.
6.
7.
8.
Fang, Chongkai, et al.. (2023). Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity. Cell Biology and Toxicology. 39(6). 2527–2549. 10 indexed citations
9.
10.
Wang, Ji-Nan, et al.. (2022). Jianpi Huayu decoction inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling. Journal of Ethnopharmacology. 294. 115360–115360. 9 indexed citations
11.
Fang, Chongkai, et al.. (2022). The Prognostic Value of Serum Apolipoprotein A-I Level and Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer Liver Metastasis. Journal of Oncology. 2022. 1–13. 4 indexed citations
12.
Fang, Chongkai, et al.. (2022). JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells. Journal of Oncology. 2022. 1–12. 10 indexed citations
13.
Huang, Yue, et al.. (2022). Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study. BMC Gastroenterology. 22(1). 458–458. 3 indexed citations
14.
Diao, Na, et al.. (2022). CircFGGY Inhibits Cell Growth, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma via Regulating the miR-545-3p/Smad7 Axis. Frontiers in Cell and Developmental Biology. 10. 850708–850708. 5 indexed citations
15.
Fang, Chongkai, et al.. (2022). Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. Scientific Reports. 12(1). 6642–6642. 23 indexed citations
16.
Yan, Qian, Chongkai Fang, Ji-Nan Wang, et al.. (2021). Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma. International Journal of General Medicine. Volume 14. 805–823. 2 indexed citations
17.
Fang, Chongkai, Jietao Lin, Tao Zhang, et al.. (2021). Metastatic Colorectal Cancer Patient With Microsatellite Stability and BRAFV600E Mutation Showed a Complete Metabolic Response to PD-1 Blockade and Bevacizumab: A Case Report. Frontiers in Oncology. 11. 652394–652394. 14 indexed citations
18.
Huang, Yuancheng, Chongkai Fang, Lina Zhao, et al.. (2021). AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis. International Journal of General Medicine. Volume 14. 3295–3312. 8 indexed citations
19.
Zhang, Tao, et al.. (2020). The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study. PLoS ONE. 15(12). e0243164–e0243164. 12 indexed citations
20.
Fang, Chongkai, Liting Yang, Ruilin Huang, et al.. (2019). Treatment of syncope in tongue cancer with palliative chemotherapy in the intensive care unit. Medicine. 98(35). e16998–e16998. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haofeng Lu Breakdown of academic impact, for papers by Yuwen Qi Breakdown of academic impact, for papers by Jinzhe Zhou Breakdown of academic impact, for papers by Linghua Zhu Breakdown of academic impact, for papers by Juliang He Breakdown of academic impact, for papers by Wen‐Bin Ding Breakdown of academic impact, for papers by Jun Wen Breakdown of academic impact, for papers by Yumin Wu Breakdown of academic impact, for papers by Yanan Xu
Rankless by CCL
2026